Результаты поиска - Helmout Modjtahedi

  • Отображение 1 - 8 результаты of 8
Отмена результатов
  1. 1
    Therapeutic application of monoclonal antibodies in cancer: advances and challenges

    Therapeutic application of monoclonal antibodies in cancer: advances and challenges по Helmout Modjtahedi, S. Ali, Sharadah Essapen

    Опубликовано 2012
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer

    A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer по Helmout Modjtahedi, Byoung Chul Cho, Martin C. Michel, Flavio Solca

    Опубликовано 2014
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines

    Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines по Aryan Stanley, G. Hossein Ashrafi, Alan M. Seddon, Helmout Modjtahedi

    Опубликовано 2017
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

    Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells по Nikolaos Ioannou, Alan M. Seddon, Angus Dalgleish, David Mackintosh, Helmout Modjtahedi

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression andin vitro invasion

    Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression andin vitro invasion по Pornchai O‐charoenrat, Peter Rhŷs‐Evans, Helmout Modjtahedi, William Court, Gary Box, Suzanne A. Eccles

    Опубликовано 2000
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells

    Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells по Nikolaos Ioannou, Angus Dalgleish, Alan M. Seddon, David Mackintosh, Ulrich Guertler, Flavio Solca, Helmout Modjtahedi

    Опубликовано 2011
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research

    Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research по Nauf Bou Antoun, Hiba-Tun-Noor A. Mahmood, Anthony J. Walker, Helmout Modjtahedi, Richard Grose, Athina‐Myrto Chioni

    Опубликовано 2025
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer

    Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer по Helmout Modjtahedi, Tamas Hickish, Margery Nicolson, J. Moore, JM Styles, S. A. Eccles, Elise Jackson, Janine Salter, John Sloane, M. Loreto Spencer, K. Priest, Isabel Smith Zubiaga, Christopher Dean, M. Gore

    Опубликовано 1996
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: